Effects of laparoscopic radiofrequency ablation combined with a levonorgestrel-releasing intrauterine system in patients with adenomyosis

In: BMC Women's Health · 2026 · doi:10.1186/s12905-026-04947-5 · W7220686434
Observational OA: gold CC0
⚙ AI-generated summary by qwen3.7-flash, 2026-10-10 ⓘ

In a retrospective cohort of patients with adenomyosis, adding a levonorgestrel-releasing intrauterine system to laparoscopic radiofrequency ablation yielded greater 12-month improvements in pain, menstrual volume, and uterine volume than ablation alone.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

⚙ AI-generated deep summary by qwen3.7-flash, 2026-10-10 · read from full text ⓘ

This single-center retrospective cohort study evaluated the clinical outcomes of 70 patients with symptomatic adenomyosis who underwent either laparoscopic radiofrequency ablation alone or the same procedure combined with a levonorgestrel-releasing intrauterine system. The researchers compared changes in visual analog scale pain scores, menstrual volume, and uterine volume over a 12-month follow-up period between the two treatment groups. Results indicated that adding the intrauterine device to radiofrequency ablation led to significantly greater reductions in pain, menstrual bleeding, and uterine size compared to ablation alone. The authors noted that these preliminary findings require confirmation through larger prospective studies with longer follow-up durations to establish definitive efficacy. This paper is centrally about adenomyosis — specifically comparing surgical ablation techniques with hormonal adjunct therapy for symptom management.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

To compare the 12-month clinical outcomes of laparoscopic RFA alone with those of laparoscopic RFA combined with LNG-IUS in patients with symptomatic adenomyosis. This single-center retrospective cohort study included 70 patients with adenomyosis who had complete 12-month follow-up data. Based on the treatment documented in their medical records, patients were classified into an RFA-alone group (group A, n = 35) and an RFA-plus-LNG-IUS group (group B, n = 35). The primary outcome was the change in VAS score from baseline to 12 months. Continuous outcomes were analyzed using two-way mixed-design repeated-measures analysis of variance, with particular attention to the group-by-time interaction. Significant group-by-time interactions were observed for VAS score, menstrual volume, and uterine volume at 12 months. Compared with RFA alone, RFA plus LNG-IUS was associated with greater reductions in VAS score (difference in change, − 0.60 points; 95% CI, − 1.06 to − 0.14; P = .012), menstrual volume (− 25.00 mL; 95% CI, − 35.11 to − 14.89; Holm-adjusted P < .001), and uterine volume (− 14.00 cm³; 95% CI, − 17.10 to − 10.90; Holm-adjusted P < .001). At 1 month, the combined-treatment group showed a greater increase in hemoglobin (difference in change, 14.00 g/L; 95% CI, 11.51 to 16.49; Holm-adjusted P < .001) and a greater reduction in CA125 (− 7.10 U/mL; 95% CI, − 11.09 to − 3.11; Holm-adjusted P = .003). No significant group-by-time interactions were observed for white blood cell count, red blood cell count, or platelet count. In this retrospective cohort, adding LNG-IUS to laparoscopic RFA was associated with greater 12-month improvements in pain, menstrual volume, and uterine volume than laparoscopic RFA alone. These preliminary findings require confirmation in larger prospective studies with longer follow-up.
Full text 4,356 characters · extracted from oa-html · 5 sections · click to expand

Abstract

Objective To compare the 12-month clinical outcomes of laparoscopic RFA alone with those of laparoscopic RFA combined with LNG-IUS in patients with symptomatic adenomyosis.

Methods

This single-center retrospective cohort study included 70 patients with adenomyosis who had complete 12-month follow-up data. Based on the treatment documented in their medical records, patients were classified into an RFA-alone group (group A, n = 35) and an RFA-plus-LNG-IUS group (group B, n = 35). The primary outcome was the change in VAS score from baseline to 12 months. Continuous outcomes were analyzed using two-way mixed-design repeated-measures analysis of variance, with particular attention to the group-by-time interaction.

Results

Significant group-by-time interactions were observed for VAS score, menstrual volume, and uterine volume at 12 months. Compared with RFA alone, RFA plus LNG-IUS was associated with greater reductions in VAS score (difference in change, − 0.60 points; 95% CI, − 1.06 to − 0.14; P = .012), menstrual volume (− 25.00 mL; 95% CI, − 35.11 to − 14.89; Holm-adjusted P < .001), and uterine volume (− 14.00 cm³; 95% CI, − 17.10 to − 10.90; Holm-adjusted P < .001). At 1 month, the combined-treatment group showed a greater increase in hemoglobin (difference in change, 14.00 g/L; 95% CI, 11.51 to 16.49; Holm-adjusted P < .001) and a greater reduction in CA125 (− 7.10 U/mL; 95% CI, − 11.09 to − 3.11; Holm-adjusted P = .003). No significant group-by-time interactions were observed for white blood cell count, red blood cell count, or platelet count.

Conclusion

In this retrospective cohort, adding LNG-IUS to laparoscopic RFA was associated with greater 12-month improvements in pain, menstrual volume, and uterine volume than laparoscopic RFA alone. These preliminary findings require confirmation in larger prospective studies with longer follow-up. Similar content being viewed by others Abbreviations - VAS: - Visual Analog Scale - LNG-IUS: - Levonorgestrel-releasing intrauterine system - RFA: - Radiofrequency ablation

Acknowledgements

We thank all patients for providing signed permission to publish this article. Funding This work was supported by the Shanxi Medical Doctor Association Project (YSXH-QL2024ZHZL014). Author information Authors and Affiliations Corresponding authors Ethics declarations Ethics approval and consent to participate The study was conducted in accordance with the Declaration of Helsinki and was approved by the Ethics Committee of the Shanxi Provincial People’s Hospital (No. 716). The requirement for informed consent was waived by the Ethics Committee because of the retrospective study design. Consent for publication Not applicable. Competing interests The authors declare no competing interests. Additional information Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. Supplementary Information Rights and permissions Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/. About this article Cite this article Guo, J., Gao, Y., Xu, L. et al. Effects of laparoscopic radiofrequency ablation combined with a levonorgestrel-releasing intrauterine system in patients with adenomyosis. BMC Women's Health (2026). https://doi.org/10.1186/s12905-026-04947-5 Received: Accepted: Published: DOI: https://doi.org/10.1186/s12905-026-04947-5

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

⚙ Ask this paper AI returns verbatim quotes from the full text · source: oa-html ⓘ

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2026) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

Source provenance

openalex
last seen: 2026-10-10T06:01:16.085653+00:00
License: CC0 · commercial use OK